Chargement en cours...
Clinical Outcomes of Tanezumab With Different Dosages for Patient With Osteoarthritis: Network Meta-Analysis
Background: Osteoarthritis (OA) high disability rate will increase as people getting older, and is the most prevalent form of arthritis in the future. This study identified the clinical effects of optimum doses of tanezumab for patients with OA. Method: Three electronic databases were searched up un...
Enregistré dans:
| Publié dans: | Front Pharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8232525/ https://ncbi.nlm.nih.gov/pubmed/34177562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.614753 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|